Search results
GSK's oncology business suffers fresh blow with Zejula setback
Reuters via Yahoo News· 2 years ago(Reuters) -Britain's GSK said on Friday it would limit the use of its ovarian cancer drug Zejula in...
UK court orders GSK to pay AstraZeneca royalties on total sales of Zejula
Reuters via Yahoo News· 1 year agoTesaro had argued the royalty was payable only on sales that are for uses claimed or covered by the...
GSK's cancer drug combination meets primary goal in late-stage trial
Reuters via Yahoo News· 6 months agoThe results from the trial showed that Jemperli plus chemotherapy followed by Jemperli and Zejula...
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
Benzinga via Yahoo Finance· 2 years agoAnaptysBio Inc (NASDAQ: ANAB), a clinical-stage biotechnology company focused on immunology...
Zai Lab Ltd (ZLAB) Reports 25% Year-Over-Year Revenue Growth in Full-Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenue: Zai Lab Ltd (NASDAQ:ZLAB) reported a 25% increase in product revenue, reaching $266.7...
GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations
Benzinga via Yahoo Finance· 2 years agoGSK plc (NYSE: GSK) would restrict the second-line maintenance indication for Zejula to only...
Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 3 months agoIt has been about a month since the last earnings report for GSK (GSK). Shares have added about 3.1%...
GSK Beats on Q1 Earnings, Lags Sales, Reaffirms 2023 Outlook
Zacks via Yahoo Finance· 1 year agoThough GSK's revenues benefit from strong growth across all segments, the declining COVID-19...
Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for GSK (GSK). Shares have added about 6.7% in...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 1 month agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...